Grief is something that we have all experienced. The process is a natural human response to tragedy and loss. It is often cyclical and traumatic. I have read and written various articles referencing the grief process. Discussions with my niece and my dear friend led me to write this week’s column. Show More Summary
Long-term therapy with Tysabri (natalizumab) significantly improved the mental state of people with secondary progressive multiple sclerosis (SPMS), according to results of a Biogen-supported study with patients taking the drug for almost two years. Show More Summary
Patients must help develop new outcome measures of multiple sclerosis (MS), since they and healthcare providers may have differing perceptions of how crucial various measures are, a new study argues. Researchers from the Multiple Sclerosis...Show More Summary
People with multiple sclerosis (MS) who feel stigmatized because of their condition are more likely to have depression, research presented at the Consortium of Multiple Sclerosis Centers Annual Meeting showed. The Pennsylvania State...Show More Summary
Multiple sclerosis (MS) patients who experienced a relapse between their first and second rounds of Lemtrada (alemtuzumab) had good treatment outcomes over the long run, according to a Phase 3 clinical trial. Those who relapsed after...Show More Summary
The latest drug media storm to erupt in Britain is “Spice,” which causes users to become living statues. Exactly a year ago, I became a living statue for six weeks, and not one reporter hassled me. That would have broken the monotony!...Show More Summary
The use of multiple sclerosis (MS) mobile apps by patients and their clinicians encourages shared decision-making and helps patients improve their outcomes, finds a study presented at the 2017 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), taking place May 24-27 in New Orleans. Show More Summary
Patients with relapsing-remitting multiple sclerosis (RRMS) regain part of their balance control after a single training session of ball-throwing exercises, finds a study supported by the National Multiple Sclerosis Society. Researchers...Show More Summary
I’ve just been reminded, as someone with multiple sclerosis, how fortunate I am to have good medical insurance. Unlike most other countries, where medical care is a right, in the U.S. that care is a privilege. Here the quality of care and too often the availability of that care depend on what you can afford. Show More Summary
The Consortium of Multiple Sclerosis Centers (CMSC) focuses on improvements and advancements in care for those living with multiple sclerosis. Typically hosting more than 2,000 attendees and 70 exhibitors, the event is the premier North...Show More Summary
Genentech has rolled out a website to connect multiple sclerosis (MS) patients and caregivers with resources that can help them. The company unveiled GatherMS at the annual meeting of the Consortium for Multiple Sclerosis Centers in New Orleans. Show More Summary
Service dogs are typically thought of as necessary companions for the visually impaired, but service and therapy dogs can be a practical solution for people with a variety of chronic illnesses. As well as being a trusted friend, service...Show More Summary
A robust, efficient method for deriving microglia, the immune cells of the brain, from human stem cells has been developed by researchers. This new protocol now enables scientists around the world to generate this critical cell type from individual patients and improve our understanding of the role of microglia neurological malfunction.
Researchers have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis. The findings help explain why women suffer autoimmune disease more frequently than men, and suggest a therapeutic target to prevent autoimmune disease in humans.
Medically active substances are normally distributed via the blood -- either directly by injection into the bloodstream or indirectly, for example through the digestive tract after oral administration. In many diseases, however, it is of decisive importance to transport the active substance as efficiently as possible to the required target site. Show More Summary
Ahead of MS Awareness Week, an international team of researchers has discovered a new cellular mechanism -- an underlying defect in brain cells -- that may cause the disease, and a potential hallmark that may be a target for future treatment of the autoimmune disorder.
A multiple sclerosis (MS) patient treated in Germany with Ocrevus (ocrelizumab) has developed the dreaded brain infection progressive multifocal leukoencephalopathy (PML). But it is not clear whether the recently approved Genentech/Roche-developed treatment is the cause. Show More Summary
One of the biggest ongoing threads we have in the forum I help admin revolves around the subject of pain. We all know how pain can be disabling, or if not disabling, still influential over our moods, our ability to sleep, our energy levels, even the decisions we make. Show More Summary